Calling all RNASeq practitioners in the drug development space...
The NGS Working Group under BPCM is working on a white paper to address best practices in RNASeq validation for use as a primary or secondary endpoint.
Can you fill out this survey where we are collecting current practices in RNASeq validation to support primary and secondary endpoints? The request would be before EOY.
https://forms.office.com/r/X00Gzw4GpE
This is key to building content for our white paper. Let me know if you have any questions at all and if you would like to join the effort.
Best,
Mark
------------------------------
Mark Wissel
Director, R&D
Eurofins Biopharma Services
Saint Charles MO
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------